The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...

The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, making it the first approved dual-agent eye drop therapy for age-related vision decline. The ...

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration ...

The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient ...

Myopia, or the need for corrected vision to focus or see objects at a distance, has become a lot more common in recent decades. Some even consider myopia, also known as nearsightedness, an epidemic.

Myopia, frequently called nearsightedness, can be as inconvenient as it is common. A vision condition that causes nearby objects to appear clear but distant ones to appear blurry, myopia can happen ...

A new treatment vertical in eye care, pharmacologic agents for refractive correction, is in the early stage of ...

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...

Presbyopia is an eye condition that causes a reduced ability to see things up close. It occurs when the eye’s lens stops focusing light correctly on the retina and usually develops later in life. The ...

The likelihood of needing reading glasses grows as you get older. Learn the key signs of presbyopia, or age-related ...